VivoSim Labs, Inc. VIVS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 112.00K | 131.00K | 142.00K | 140.00K | 142.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 112.00K | 131.00K | 142.00K | 140.00K | 142.00K |
| Cost of Revenue | 4.32M | 4.19M | 3.92M | 4.57M | 4.63M |
| Gross Profit | -4.21M | -4.06M | -3.78M | -4.43M | -4.49M |
| SG&A Expenses | 7.12M | 7.43M | 7.67M | 7.75M | 7.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.44M | 11.62M | 11.60M | 12.31M | 12.29M |
| Operating Income | -11.33M | -11.49M | -11.45M | -12.17M | -12.15M |
| Income Before Tax | -12.33M | -13.84M | -1.23M | -1.98M | -1.99M |
| Income Tax Expenses | 5.00K | 2.00K | 2.00K | 2.00K | 0.00 |
| Earnings from Continuing Operations | -12.34 | -13.84 | -1.23 | -1.98 | -1.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.34M | -13.84M | -1.23M | -1.98M | -1.99M |
| EBIT | -11.33M | -11.49M | -11.45M | -12.17M | -12.15M |
| EBITDA | -11.14M | -11.27M | -11.22M | -11.92M | -11.89M |
| EPS Basic | -4.45 | -5.33 | 1.07 | -0.19 | -0.91 |
| Normalized Basic EPS | -2.80 | -3.35 | -3.17 | -3.96 | -4.41 |
| EPS Diluted | -4.45 | -5.33 | 1.07 | -0.19 | -0.91 |
| Normalized Diluted EPS | -2.80 | -3.35 | -3.17 | -3.96 | -4.41 |
| Average Basic Shares Outstanding | 13.09M | 10.35M | 9.34M | 8.24M | 7.13M |
| Average Diluted Shares Outstanding | 13.09M | 10.35M | 9.34M | 8.24M | 7.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |